The results of a study presented during the Radiological Society of North America's annual meeting found that Ga-68 PSMA PET/MR is better than MRI alone at identifying biochemically recurrent prostate cancer. "PSMA PET is a more robust modality for biochemical recurrence with the potential of identifying small lesions which would otherwise be dismissed on MRI alone. We recommend the use of 68Ga PSMA PET/MR for biochemical recurrent prostate cancer with potential to be the new standard of care for this indication," wrote the researchers.
Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession.